Role of hypocretin/orexin in the neurobiology of sleep and alertness

Narcolepsy and Hypersomnia

Volumn , Issue , 2006, Pages 359-374

  Zeitzer, Jamie M ^a   Mignot, Emmanuel ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 70349672841     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (58)

1. de Lecea L, Kilduff TS, Peyron C, Gao X-B, Foye PE, Danielson PE et al. The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity. Proceedings of the National Academy of Sciences USA 1998; 95:322-327.
2. Sakurai T, Amemiya A, Ishii M, Matsuzaki I, Chemelli RM, Tanaka H et al. Orexins and orexin receptors: a family of hypothalamic neuropeptides and g protein-coupled receptors that regulate feeding behavior. Cell 1998; 92:573-585.
3. van den Pol AN. Hypothalamic hypocretin (orexin): robust innervation of the spinal cord. Journal of Neuroscience 1999; 19(8):3171-3182.
4. Peyron C, Tighe DK, van den Pol A, de Lecea L, Heller HC, Sutcliffe JG et al. Neurons containing hypocretin (orexin) project to multiple neuronal systems. Journal of Neuroscience 1998; 18(23): 9996-10015.
5. Date Y, Ueta Y, Yamashita H, Yamaguchi H, Matsukura S, Kangawa K et al. Orexins, orexigenic hypothalamic peptides, interact with autonomic, neuroendocrine and neuroregulatory systems. Proceedings of the National Academy of Sciences USA 1999; 96:748-753.
6. Trivedi P, Yu H, MacNeil DJ, van der Ploeg LHT, Guan X-M. Distribution of orexin receptor mRNA in the rat brain. FEBS Letters 1998; 438:71-75.
7. Marcus JN, Aschkenasi CJ, Lee CE, Chemelli RM, Saper CB, Yanagisawa M et al. Differential expression of orexin receptors 1 and 2 in the rat brain. Journal of Comparative Neurology 2001; 435:6-25.
8. Burdakov D, Liss B, Ashcroft FM. Orexin excites GABAergic neurons of the arcuate nucleus by activating the sodium-calcium exchanger. Journal of Neuroscience 2003; 23(12):4951-4957.
9. Hoang QV, Bajic D, Yanagisawa M, Nakajima S, Nakajima Y. Effects of orexin (hypocretin) on GIRK channels. Journal of Neurophysiology 2003; 90(693):702.
10. Willie JT, Chemelli RM, Sinton CM, Tokita S, Williams SC, Kisanuki YY et al. Distinct narcolepsy syndromes in orexin receptor-2 and orexin null mice: molecular genetic dissection of non-REM and REM sleep regulatory processes. Neuron 2003; 38:715-730.
11. Ida T, Nakahara K, Katayama T, Murakami N, Nakazato M. Effect of lateral cerebroventricular injection of the appetite-stimulating neuropeptide, orexin and neuropeptide Y, on the various behavioral activities of rats. Brain Research 1999; 821:526-529.
12. Hagan JJ, Leslie RA, Patel S, Evans ML, Wattam TA, Holmes S et al. Orexin A activates locus coeruleus cell firing and increases arousal in the rat. Proceedings of the National Academy of Sciences USA 1999; 96:10911-10916.
13. Nakamura T, Uramura K, Nambu T, Yada T, Goto K, Yanagisawa M et al. Orexin-induced hyperlocomotion and stereotypy are mediated by the dopaminergic system. Brain Research 2000; 873: 181-187.
14. Yoshimichi G, Yoshimatsu H, Masaki T, Sakata T. Orexin-A regulates body temperature in coordination with arousal status. Experimental Biology and Medicine 2001; 226(5):468-476.
15. España RA, Plahn S, Berridge CW. Circadian-dependent and circadian-independent behavioral actions of hypocretin/orexin. Brain Research 2002; 943:224-236.
16. Dantz B, Edgar DM, Dement WC. Circadian rhythms in narcolepsy: studies on a 90 minute day. Electroencephalography and Clinical Neurophysiology 1994; 90:24-35.
17. Broughton R, Krupa S, Boucher B, Rivers M, Mullington J. Impaired circadian waking arousal in narcolepsy-cataplexy. Sleep Research Online 1998; 1(4):159-165.
18. Bourgin P, Huitrón-Reséndiz S, Spier AD, Fabre V, Morte B, Criado JR et al. Hypocretin-1 modulates rapid eye movement sleep through activation of locus coeruleus neurons. Journal of Neuroscience 2000; 20(20):7760-7765.
19. Xi M-C, Morales FR, Chase MH. Effects on sleep and wakefulness of the injection of hypocretin-1 (orexin-A) into the laterodorsal tegmental nucleus of the cat. Brain Research 2001; 901:259-264.
20. Yamanaka A, Tsujino N, Funahashi H, Honda K, Guan J, Wang Q-P et al. Orexins activate histaminergic neurons via the orexin 2 receptor. Biochemical and Biophysical Research Communications 2002; 290:1237-1245.
21. Eriksson KS, Sergeeva O, Brown RE, Haas HL. Orexin/hypocretin excites the histaminergic neurons of the tuberomammillary nucleus. Journal of Neuroscience 2002; 21(23):9273-9279.
22. Ishizuka T, Yamamoto Y, Yamatodani A. The effect of orexin-A and-B on the histamine release in the anterior hypothalamus in rats. Neuroscience Letters 2002; 323:93-96.
23. Huang Z-L, Qu W-M, Li W-D, Mochizuki T, Eguchi N, Watanabe T et al. Arousal effect of orexin A depends on activation of the histaminergic system. Proceedings of the National Academy of Sciences USA 2001; 98(17):9965-9970.
24. Hoffman GE, Lyo D. Anatomical markers of activity in neuroendocrine systems: are we all ‘fos-ed out’? Journal of Neuroendocrinology 2002; 14:259-268.
25. Zhang S, Zeitzer JM, Yoshida Y, Wisor JP, Nishino S, Edgar DM et al. Lesions of the suprachiasmatic nucleus eliminate the daily rhythm of hypocretin-1 release. Sleep 2004; 27(4):619-627.
26. Deboer T, Overeem S, Visser NA, Duindam H, Frolich M, Lammers G et al. Hypocretin-1 is under influence of circadian and homeostatic mechanisms. Sleep 2004; 27:A1-A2.
27. Abrahamson EE, Leak RK, Moore RY. The suprachiasmatic nucleus projects to posterior hypothalamic arousal systems. NeuroReport 2001; 12(2):435-440.
28. Chou TC, Scammell TE, Gooley JJ, Gaus SE, Saper CB, Lu J. Critical role of dorsomedial hypothalamic nucleus in a wide range of behavioral circadian rhythms. Journal of Neuroscience 2003; 23(33): 10691-10702.
29. Di Chiro G, Larson SM, Harrington T, Johnston GS, Green MV, Swann SJ. Descent of cerebrospinal fluid to spinal subarachnoid space. Acta Radiologica (Diagnosis) 1973; 14:379-384.
30. Abrahamson EA, Moore RY. The posterior hypothalamic area: chemoarchitecture and afferent connections. Brain Research 2001; 889:1-22.
31. Campbell RE, Smith MS, Allen SE, Grayson BE, ffrench-Mullen JMH, Grove KL. Orexin neurons express a functional pancreatic polypeptide Y4 receptor. Journal of Neuroscience 2003; 23(4):1487-1497.
32. Elias CF, Saper CB, Maratos-Flier E, Tritos NA, Lee C, Kelly J et al. Chemically defined projections linking the mediobasal hypothalamus and the lateral hypothalamic area. Journal of Comparative Neurology 1998; 402:442-459.
33. Yamanaka A, Beuckmann CT, Willie JT, Hara J, Tsujino N, Mieda M et al. Hypothalamic orexin neurons regulate arousal according to energy balance in mice. Neuron 2003; 38:701-713.
34. Fujiki N, Yoshida Y, Ripley B, Honda K, Mignot E, Nishino S. Changes in CSF hypocretin-1 (orexin A) levels in rats across 24 hours and in response to food deprivation. NeuroReport 2001; 12(5):993-997.
35. Wu M-F, John J, Maidment N, Lam HA, Siegel JM. Hypocretin release in normal and narcoleptic dogs after food and sleep deprivation, eating, and movement. American Journal of Physiology 2002; 283:R1079-R1086.
36. Salomon RM, Ripley B, Kennedy JS, Johnson B, Zeitzer JM, Nishino S et al. Diurnal variation of CSF hypocretin-1 (orexin-A) levels in control and depressed subjects. Biological Psychiatry 2003; 54:96-104.
37. Blank JL, Desjardins C. Differential effects of food restriction on pituitary-testicular function in mice. American Journal of Physiology 1985; 248:R181-R189.
38. Bae HH, Larkin JE, Zucker I. Juvenile Siberian hamsters display torpor and modified locomotor activity and body temperature rhythms in response to reduced food availability. Physiological and Biochemical Zoology 2003; 76(6):858-867.
39. Yoshida Y, Fujiki N, Nakajima T, Ripley B, Matsumura H, Yoneda H et al. Fluctuation of extracellular hypocretin-1 (orexin A) levels in the rat in relation to the light-dark cycle and sleep-wake activities. European Journal of Neuroscience 2001; 14:1075-1081.
40. Zeitzer JM, Buckmaster CL, Lyons DM, Mignot E. Locomotor-dependent and-independent components to hypocretin-1 (orexin A) regulation in sleep-wake consolidating monkeys. Journal of Physiology 2004; 557(3):1045-1053.
41. Martins PJF, D’Almeida V, Pedrazzoli M, Lin L, Mignot E, Tufik S. Increased hypocretin-1 (orexin-a) levels in cerebrospinal fluid of rats after short-term forced activity. Regulatory Peptides 2004; 117: 155-158.
42. Torterolo PD, Sampogna S, Ramos O, Morales FR, Chase MH. Fos immunoreactivity in hypocretinergic and MCHergic neurons in the cat during different somatomotor behaviors. Society for Neuroscience 34, 437.16. 2004.
43. Welsh DK, Richardson GS, Dement WC. Effect of running wheel availability on circadian patterns of sleep and wakefulness in mice. Physiology and Behavior 1988; 43:771-777.
44. Torterolo P, Yamuy J, Sampogna S, Morales FR, Chase MH. Hypothalamic neurons that contain hypocretin (orexin) express c-fos during active wakefulness and carbachol-induced active sleep. Sleep Research Online 2001; 4(1):25-32.
45. Zeitzer JM, Buckmaster CL, Parker KJ, Hauck CM, Lyons DM, Mignot E. Circadian and homeostatic regulation of hypocretin in a primate model: implications for the consolidation of wakefulness. Journal of Neuroscience 2003; 23(8):3555-3560.
46. Yamanaka A, Muraki Y, Tsujino N, Goto K, Sakurai T. Regulation of orexin neurons by the monoaminergic and cholinergic systems. Biochemical and Biophysical Research Communications 2003; 303:120-129.
47. Li Y, Gao X-B, Sakurai T, van den Pol AN. Hypocretin/orexin excites hypocretin neurons via a local glutamate neuron-a potential mechanism for orchestrating the hypothalamic arousal system. Neuron 2002; 36:1169-1181.
48. Lee M, Jones BE. Discharge of identified orexin neurons across the sleep-waking cycle. Society for Neuroscience 34, 841.1. 2004.
49. Kiyashchenko LI, Mileykovskiy BY, Maidment NT, Lam HA, Wu M-F, John J et al. Release of hypocretin (orexin) during waking and sleep states. Journal of Neuroscience 2002; 22(13):5282-5286.
50. Dijk D-J, Czeisler CA. Paradoxical timing of the circadian rhythm of sleep propensity serves to consolidate sleep and wakefulness in humans. Neuroscience Letters 1994; 166:63-68.
51. Mignot E, Lammers GJ, Ripley B, Okun M, Nevsimalova S, Overeem S et al. The role of cerebrospinal fluid hypocretin measurement in the diagnosis of narcolepsy and other hypersomnias. Archives of Neurology 2002; 59:1553-1562.
52. John J, Wu M-F, Boehmer LN, Siegel JM. Cataplexy-active neurons in the hypothalamus: implications for the role of histamine in sleep and waking behavior. Neuron 2004; 42(4):619-634.
53. Kisanuki YY, Chemelli RM, Sinton CM, Williams SC, Richardson JA, Hammer RE et al. The role of orexin receptor type-1 (OX1R) in the regulation of sleep. Sleep 23, A91. 2000.
54. Daniels LE. Narcolepsy. Medicine (Baltimore) 1934; 13:121-122.
55. Okun ML, Lin L, Pelin Z, Hong S, Mignot E. Clinical aspects of narcolepsy-cataplexy across ethnic groups. Sleep 2002; 25(1):27-35.
56. Saper CB, Chou TC, Scammell TE. The sleep switch: hypothalamic control of sleep and wakefulness. Trends in Neurosciences 2001; 24(12):726-731.
57. Taheri S, Sunter D, Dakin C, Moyes S, Seal L, Gardiner J et al. Diurnal variation in orexin A immunoreactivity and prepro-orexin mRNA in the rat central nervous system. Neuroscience Letters 2000; 279:109-112.
58. Estabrooke IV, McCarthy MT, Ko E, Chou TC, Chemelli RM, Yanagisawa M et al. Fos expression in orexin neurons varies with behavioral state. Journal of Neuroscience 2001; 21(5):1656-1662.